PRESS RELEASE published on 01/11/2024 at 18:00, 2 years 9 months ago BioGX Expands PCR Test Menu at State Departments of Health BioGX, a leading provider of molecular diagnostic solutions, has announced the expansion of its test menu to support state Departments of Health with the addition of its Candida auris assay. This expansion will provide access to BioGX's molecular assays designed for speed, precision, and reliability, empowering healthcare professionals with the best tools available to improve public health outcomes. Healthcare Professionals BioGX Molecular Diagnostic Solutions Candida Auris Assay Public Health
PRESS RELEASE published on 07/24/2023 at 06:00, 3 years 2 months ago BioGX Candida Auris PCR Assay Global Adoption Accelerates
PRESS RELEASE published on 03/23/2023 at 19:00, 3 years 6 months ago BioGX Candida Auris PCR Assay Adoption Accelerates
PRESS RELEASE published on 02/28/2023 at 21:00, 3 years 7 months ago BioGX Ships First Batch of pixl(TM) Real-Time PCR Platform to US Laboratories
Published on 10/13/2026 at 14:10, 10 minutes ago NioCorp Places 100% of Its Planned Critical Minerals Production Under Commercial Sales Agreements
Published on 10/13/2026 at 14:00, 20 minutes ago Orogen Royalties Enters into Agreement to Sell the Slaughterhouse Copper-Gold Project to Seabridge Gold
Published on 10/13/2026 at 14:00, 20 minutes ago Fermi Signs Credit Support Agreement with AMD and Announces Partnership
Published on 10/13/2026 at 13:30, 50 minutes ago British Columbia Court Declares The Helix Resources Joint Venture on The Gold Basin Property is Set Aside and is Unenforceable
Published on 10/13/2026 at 13:30, 50 minutes ago Digi Power X Announces $200 Million Debt Financing Commitment to Support Completion of Alabama AI Data Center and Provides Expansion Update
Published on 10/13/2026 at 14:05, 15 minutes ago IDC Raises 2029 Forecast for OCP-Recognized Infrastructure Spending by 2.7x to $800 Billion
Published on 10/13/2026 at 14:00, 20 minutes ago Eckert & Ziegler and TerThera Sign Supply Agreement to Bring Next-Generation GMP Terbium-161 Radiopharmaceutical Therapies to Brazilian Patient
Published on 10/13/2026 at 13:14, 1 hour 5 minutes ago EQS-Adhoc: ElringKlinger raises 2026 full-year revenue guidance
Published on 10/13/2026 at 09:04, 5 hours 15 minutes ago Peru Is Recognized as “South America's Leading Destination” at the World Travel Awards
Published on 10/12/2026 at 17:59, 20 hours 20 minutes ago Reporting on share buyback transactions carried out between October 7 and October 9, 2026
Published on 10/12/2026 at 17:45, 20 hours 35 minutes ago Declaration of transactions on own shares from October 5, 2026 to October 11, 2026
Published on 10/12/2026 at 15:47, 22 hours 32 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of September 30, 2026